# A Pharmacokinetic Study of YM178 in Normal Subjects and Those With Mild, Moderate, and Severe Renal Impairment

> **NCT00750620** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 33 (actual)

## Conditions studied

- Renal Impairment

## Interventions

- **DRUG:** YM178

## Key facts

- **NCT ID:** NCT00750620
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2013-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00750620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00750620, "A Pharmacokinetic Study of YM178 in Normal Subjects and Those With Mild, Moderate, and Severe Renal Impairment". Retrieved via AI Analytics 2026-09-11 from https://api.ai-analytics.org/clinical/NCT00750620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*